Patents by Inventor Peter Baluk

Peter Baluk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cationic lipid compositions targeting angiogenic endothelial cells
    Patent number: 7094424
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Grant
    Filed: November 3, 2003
    Date of Patent: August 22, 2006
    Assignee: The Regents of the University of California
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Patent number: 6756055
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Grant
    Filed: May 29, 2002
    Date of Patent: June 29, 2004
    Assignee: The Regents of the University of California
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Publication number: 20040072795
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Application
    Filed: November 3, 2003
    Publication date: April 15, 2004
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Publication number: 20030077305
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Application
    Filed: November 22, 2002
    Publication date: April 24, 2003
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Publication number: 20020197306
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Application
    Filed: November 14, 2001
    Publication date: December 26, 2002
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Publication number: 20020155102
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Application
    Filed: May 29, 2002
    Publication date: October 24, 2002
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Patent number: 6120799
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: September 19, 2000
    Assignee: The Regents of the University of California
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk
  • Cationic lipid compositions targeting angiogenic endothelial cells
    Patent number: 5837283
    Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: November 17, 1998
    Assignee: The Regents of the University of California
    Inventors: Donald M. McDonald, John McLean, O. Gavin Thurston, Peter Baluk